1. Home
  2. RVPHW vs LSB Comparison

RVPHW vs LSB Comparison

Compare RVPHW & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPHW
  • LSB
  • Stock Information
  • Founded
  • RVPHW N/A
  • LSB 2002
  • Country
  • RVPHW United States
  • LSB China
  • Employees
  • RVPHW 15
  • LSB N/A
  • Industry
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • LSB
  • Sector
  • RVPHW Health Care
  • LSB
  • Exchange
  • RVPHW Nasdaq
  • LSB NYSE
  • Market Cap
  • RVPHW N/A
  • LSB 72.7M
  • IPO Year
  • RVPHW 2018
  • LSB N/A
  • Fundamental
  • Price
  • RVPHW $0.10
  • LSB $3.80
  • Analyst Decision
  • RVPHW
  • LSB
  • Analyst Count
  • RVPHW 0
  • LSB 0
  • Target Price
  • RVPHW N/A
  • LSB N/A
  • AVG Volume (30 Days)
  • RVPHW N/A
  • LSB 115.6K
  • Earning Date
  • RVPHW N/A
  • LSB 10-25-2024
  • Dividend Yield
  • RVPHW N/A
  • LSB N/A
  • EPS Growth
  • RVPHW N/A
  • LSB N/A
  • EPS
  • RVPHW N/A
  • LSB N/A
  • Revenue
  • RVPHW N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • RVPHW N/A
  • LSB $39.33
  • Revenue Next Year
  • RVPHW N/A
  • LSB $75.61
  • P/E Ratio
  • RVPHW N/A
  • LSB N/A
  • Revenue Growth
  • RVPHW N/A
  • LSB N/A
  • 52 Week Low
  • RVPHW N/A
  • LSB $3.20
  • 52 Week High
  • RVPHW N/A
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • RVPHW N/A
  • LSB 33.85
  • Support Level
  • RVPHW N/A
  • LSB $3.20
  • Resistance Level
  • RVPHW N/A
  • LSB $4.14
  • Average True Range (ATR)
  • RVPHW 0.00
  • LSB 0.72
  • MACD
  • RVPHW 0.00
  • LSB -0.44
  • Stochastic Oscillator
  • RVPHW 0.00
  • LSB 11.11

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: